Niger vs South Sudan: Access to anti-retroviral drugs, male
Niger
56.0%
in 2024
South Sudan
52.0%
in 2024
Niger rank
110th
South Sudan rank
113th
Access to anti-retroviral drugs, male over time
- Niger
- South Sudan
How they compare
Niger currently reports 56.0% against 52.0% in South Sudan, a difference of 4.0%.
That makes Niger's figure about 1.1 times South Sudan's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was South Sudan ahead.
Niger ranks 110th and South Sudan ranks 113th of 141 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niger | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 0.1% | 3.3% | Niger |
| 2010s | 32.7% | 10.0% | 22.7% | Niger |
| 2020s | 56.0% | 39.4% | 16.6% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Niger or South Sudan?
- Niger, at 56.0% against 52.0% in South Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Niger and South Sudan?
- 4.0%, with Niger ahead.
- How many years of comparable data are there for Niger and South Sudan?
- 25 years are reported by both, from 2000 to 2024.
- How do Niger and South Sudan rank globally for access to anti-retroviral drugs, male?
- Niger ranks 110th and South Sudan ranks 113th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.